Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04140344 · ClinicalTrials.gov registry record · NA

The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions

A NA study of Lumbar Spine Degeneration and Lumbar Spondylosis, sponsored by Duke University.

Recruiting
Registry status
NA
Development phase
224
Enrollment target
1
Study location

NCT04140344: Recruiting NA study of Lumbar Spine Degeneration and Lumbar Spondylosis, sponsored by Duke University.

NCT04140344 is a NA study of Lumbar Spine Degeneration and Lumbar Spondylosis that is actively recruiting participants, run by Duke University. The registered enrollment target is 224 participants, below the 612-participant average among 7 other Lumbar Spine Degeneration trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04140344, a NA study of Lumbar Spine Degeneration and Lumbar Spondylosis, is actively recruiting participants, sponsored by Duke University.

RECRUITING
Registry status
NA
Development phase
224 participants
Enrollment target
1
Study location

Study Summary

The purpose of this single-blind, randomized, controlled study is to assess the efficacy of "informative text messages" vs "traditional handouts" provided to lumbar spine surgery patients post-operatively.

Primary Outcome

Change in readmission rates within 30 days post-lumbar spine surgery as measured by questionnaire.

Interventions

  • OTHER Text Message Group

Study Locations (1)

North Carolina

  • Duke Neurosurgery and Duke Orthopedics - Durham

Trial Details

FieldValue
Enrollment Target 224 participants
Start Date 2023-09-07
Est. Completion 2027-10
Phase NA
Duke University

1,725 total trials

What NCT04140344 shows while recruiting

NCT04140344 is an interventional study that assigns participants to a tested intervention. The registered 224 participants enrollment target is mid-sized for trials with a published cap, below the 612-participant average among 7 other Lumbar Spine Degeneration trials with a reported enrollment target (63% lower).

The record links to 3 conditions, with Lumbar Spine Degeneration appearing as the primary indexed condition, and to 1 intervention - of which Text Message Group is the first listed.

NCT04140344 reports a single indexed study location in North Carolina.

Frequently Asked Questions

What is clinical trial NCT04140344 about?

NCT04140344 is a clinical study titled "The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions". The purpose of this single-blind, randomized, controlled study is to assess the efficacy of "informative text messages" vs "traditional handouts" provided to lumbar spine surgery patients post-operatively.

What is the current status of trial NCT04140344?

This trial is currently recruiting. It is a NA study. The enrollment target is 224 participants. The study started on 2023-09-07. Estimated completion is 2027-10.

What conditions does trial NCT04140344 study?

This clinical trial studies the following conditions: Lumbar Spine Degeneration, Lumbar Spondylosis, Lumbar Spine Instability.

What interventions are being tested in trial NCT04140344?

The interventions under investigation include: Text Message Group (OTHER).

Who is sponsoring clinical trial NCT04140344?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04140344 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lumbar Spine Degeneration

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02706561 · 224 participants · NA

    Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery

  • NCT04915183 · 224 participants · Phase 2

    Atorvastatin to Reduce Cisplatin-Induced Hearing Loss Among Individuals With Head and Neck Cancer

  • NCT05519878 · 224 participants · NA

    Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers

  • NCT05559671 · 224 participants · Phase 4

    Safety of the Herpes Zoster Subunit Vaccine in Lupus

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04140344, the US trial registry maintained by the National Library of Medicine. NCT04140344 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.